We are harnessing the biology of human aging to develop new therapies for metabolic diseases

We are harnessing the biology of human aging to develop new therapies for metabolic diseases

We are harnessing the biology of human aging to develop new therapies for metabolic diseases

Find out more

Harnessing aging to transform health

Obesity and other metabolic diseases are among the most prevalent and pressing health challenges of our time.

Age is a critical risk factor.

linkGoogle

Azelaprag for obesity

Our lead program, azelaprag, has potential to be a first and best-in-class oral weight loss therapy co-administered with incretin drugs to achieve injectable-like total weight loss.

linkGoogle

Discovery platform

Our human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify the molecular mediators of aging and disease.

Our pipeline programs target key pathways that drive metabolic aging based on novel insights from our platform.

linkGoogle
Left gradient Right gradient